Drug Detail

Drug Name RXDX-105
Trade Name
Synonyms AC013773|CEP-32496
Drug Descriptions

RXDX-105 (CEP-32496) inhibits wild-type BRAF, BRAF V600E, c-RAF, ABL1 (and BCR-ABL), c-KIT, RET, PDGFR beta, and VEGFR2, potentially resulting in decreased tumor growth (PMID: 22319199).

DrugClasses ABL Inhibitor (pan) 8 ABL1 Inhibitor 5 BCR-ABL Inhibitor 24 BRAF Inhibitor 19 CRAF Inhibitor 11 KIT Inhibitor 50 PDGFR-beta Inhibitor 13 RET Inhibitor 36 VEGFR2 Inhibitor 34


  • Case insensitive filtering will display rows where any text in any cell matches the filter term
  • Simple literal full or partial string matches
  • Separate multiple filter terms with a spaces, order doesn't matter (a b c and c b a are equivalent )
  • Filtering will only apply to rows that are already loaded on the page, filtering has no impact on query parameters
  • Use quotes to match a longer phrase which contains spaces "mtor c1483f"


  • Generally, the default sort order for tables is set to be first column ascending, however, specific tables may set a different default sort order.
  • Click on any column header arrows to sort by that column
  • Hold down the Shift key and click multiple columns to sort by more than one column, be sure to set ascending or descending order for a given column, before moving on to the next column.

Therapy Name Drugs Efficacy Evidence Clinical Trials
RXDX-105 RXDX-105 8 3

Additional content available in CKB BOOST